Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
32 hedge funds and large institutions have $51.3M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 6 closing their positions.
14% less funds holding
Funds holding: 37 → 32 (-5)
20% less capital invested
Capital invested by funds: $64.4M → $51.3M (-$13.1M)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$41.7K |
| 2 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$41.7K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$7.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
-$4.17M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$3.31M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.03M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$511K |
| 5 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$254K |
FLACU Hedge Fund Activity: Q2 2021 in Review
32 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q2 2021, worth a combined $51.3M — down 20% from $64.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FLACU and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 2 added.
The largest buyer was Boothbay Fund Management, adding an estimated $41.7K. The largest seller was MYDA Advisors, exiting entirely with an estimated $4.17M sold.
- 32 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q2 2021, down from 37 in Q1 2021.
- Funds reported $51.3M of Frazier Lifesciences Acquisition Corporation Unit stock for Q2 2021, down 20% quarter-over-quarter.
- 1 fund opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q2 2021 and 6 closed out, a net change of -5 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q2 2021 was Boothbay Fund Management, an estimated $41.7K added.
- The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q2 2021 was MYDA Advisors, an estimated $4.17M sold.
Based on aggregated 13F filings for Q2 2021.